Note: You clicked on an external link, which has been disabled in order to keep your shopping session open.
|Tested species reactivity||Human|
|Published species reactivity||Human|
|Host / Isotype||Goat / IgG|
|Immunogen||Full length protein (Human Apolipoprotein A II).|
|Purification||Antigen affinity chromatography|
|Storage buffer||PBS, pH 7.4, with 10mg/ml BSA|
|Storage Conditions||Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.|
|Tested Applications||Dilution *|
|Western Blot (WB)||1:1500-1:6000|
* Suggested working dilutions are given as a guide only. It is recommended that the user titrate the product for use in their own experiment using appropriate negative and positive controls.
PA1-28972 detects Apo AII from human samples.
PA1-28972 has been successfully used in Western blot and ELISA applications. Predicted molecular weight: 11 kDa.
The PA1-28972 immunogen is: Full length protein (Human Apolipoprotein A II).
Store at 4°C short term. For extended storage, aliquot and store at -20°C or below. Avoid freeze-thaw cycles.
For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.
Activation of paraoxonase 1 after hemodialysis is associated with HDL remodeling and its increase in the HDL2 fraction and VLDL.
PA1-28972 was used in immunocytochemistry and western blot to study the role of HDL remodeling in the mechanism by which hemodialysis leads to activation of paroxonase-1
|Gugliucci A,Kinugasa E,Ogata H,Caccavello R,Kimura S||Clinica chimica acta; international journal of clinical chemistry (430:9)||2014|
Activation of paraoxonase 1 is associated with HDL remodeling ex vivo.
PA1-28972 was used in western blot to study ex vivo remodeling of HDL and the role of paroxonase-1 activation
|Gugliucci A||Clinica chimica acta; international journal of clinical chemistry (429:38)||2014|
Apo-AII; Apolipoprotein A-II; Apolipoprotein A2
Apo-AII; ApoA-II; APOA2; apoAII